V

Vcanbio Cell & Gene Engineering Corp Ltd
SSE:600645

Watchlist Manager
Vcanbio Cell & Gene Engineering Corp Ltd
SSE:600645
Watchlist
Price: 26.67 CNY -2.2% Market Closed
Market Cap: 12.5B CNY

Profitability Summary

Vcanbio Cell & Gene Engineering Corp Ltd's profitability score is hidden . We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Sign Up to see
Profitability Score
Sign In
Sign Up

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Sign Up to see
Profitability Score
Sign In
Sign Up

Margins

Earnings Waterfall
Vcanbio Cell & Gene Engineering Corp Ltd

Margins Comparison
Vcanbio Cell & Gene Engineering Corp Ltd Competitors

Country Company Market Cap Gross
Margin
Operating
Margin
Net
Margin
CN
Vcanbio Cell & Gene Engineering Corp Ltd
SSE:600645
12.5B CNY
Loading...
Loading...
Loading...
FR
Pharnext SCA
OTC:PNEXF
6T USD
Loading...
Loading...
Loading...
US
Abbvie Inc
NYSE:ABBV
378.8B USD
Loading...
Loading...
Loading...
US
Amgen Inc
NASDAQ:AMGN
177.8B USD
Loading...
Loading...
Loading...
US
Gilead Sciences Inc
NASDAQ:GILD
155.1B USD
Loading...
Loading...
Loading...
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
112.1B USD
Loading...
Loading...
Loading...
US
Epizyme Inc
F:EPE
94.1B EUR
Loading...
Loading...
Loading...
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
77.2B USD
Loading...
Loading...
Loading...
AU
CSL Ltd
ASX:CSL
85B AUD
Loading...
Loading...
Loading...
NL
argenx SE
XBRU:ARGX
42.4B EUR
Loading...
Loading...
Loading...
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
47.3B USD
Loading...
Loading...
Loading...
No Stocks Found

Return on Capital

Return on Capital Comparison
Vcanbio Cell & Gene Engineering Corp Ltd Competitors

Country Company Market Cap ROE ROA ROCE ROIC
CN
Vcanbio Cell & Gene Engineering Corp Ltd
SSE:600645
12.5B CNY
Loading...
Loading...
Loading...
Loading...
FR
Pharnext SCA
OTC:PNEXF
6T USD
Loading...
Loading...
Loading...
Loading...
US
Abbvie Inc
NYSE:ABBV
378.8B USD
Loading...
Loading...
Loading...
Loading...
US
Amgen Inc
NASDAQ:AMGN
177.8B USD
Loading...
Loading...
Loading...
Loading...
US
Gilead Sciences Inc
NASDAQ:GILD
155.1B USD
Loading...
Loading...
Loading...
Loading...
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
112.1B USD
Loading...
Loading...
Loading...
Loading...
US
Epizyme Inc
F:EPE
94.1B EUR
Loading...
Loading...
Loading...
Loading...
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
77.2B USD
Loading...
Loading...
Loading...
Loading...
AU
CSL Ltd
ASX:CSL
85B AUD
Loading...
Loading...
Loading...
Loading...
NL
argenx SE
XBRU:ARGX
42.4B EUR
Loading...
Loading...
Loading...
Loading...
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
47.3B USD
Loading...
Loading...
Loading...
Loading...
No Stocks Found

Free Cash Flow

Free Cash Flow Analysis
Vcanbio Cell & Gene Engineering Corp Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate